Current evaluation of alemtuzumab in multiple sclerosis

By Coyle Patricia Katherine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 127-135

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of IL-27 in multiple sclerosis?

By Fitzgerald Denise C   Rostami Abdolmohamad  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 149-160

Informa Healthcare

Access to resources Recommend Favorite

Tovaxin for multiple sclerosis

By Rivera Victor M  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 961-967

Informa Healthcare

Access to resources Recommend Favorite

On the Catalytic Activity of Autoantibodies in Multiple Sclerosis

By Ponomarenko N. A.   Durova O. M.   Vorob'ev I. I.   Suchkov S. V.   Gabibov A. G.  

Doklady Biochemistry & Biophysics, Vol. 395, Iss. 1-6, 2004-03 ,pp. : 120-123

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Spasticity in multiple sclerosis: results of a patient survey

By Oreja-Guevara C.  

International Journal of Neuroscience, Vol. 123, Iss. 6, 2013-04 ,pp. : 400-408

Informa Healthcare

Access to resources Recommend Favorite